Section 373-5-4 - Treatment Protocol ContentA treatment protocol shall describe the activities that the pharmacist is authorized to engage in and must, at a minimum, include the requirements set forth below.
1.Informed Consent Procedures.The protocol shall specify the procedures for obtaining informed consent from each patient involved in the drug therapy management, which consent shall include the patients' consent to release all relevant medical information to both the practitioner and the pharmacist.2.Scope of Activities.A description of the activities the pharmacist is authorized to engage in, including the procedures, decision criteria, or plan the pharmacist shall follow when providing drug therapy management pursuant to a medical order from the practitioner.3.Documentation.A description of the manner in which the pharmacist shall document all activities involved in providing drug therapy management in collaboration with a practitioner.4.Communication.A description of the procedures the pharmacist shall follow for reporting activities and results to the practitioner, including but not limited to:A. A description of the timeframe in which the pharmacist must relay normal test results to the practitioner, not to exceed one week for routine results and twenty-four hours for abnormal results; andB. A description of the timeframe in which the pharmacist must relay adverse drug events, not to exceed twenty-four hours.5.Supervision. A. A provision that allows the practitioner to override a collaborative practice decision made by the pharmacist when appropriate; andB. A provision that provides for periodic review and revision of the drug therapy management by the practitioner and pharmacist.